PDGF receptor beta binding polypeptides
US11136398B2 · kind B2 · utility
0Cited by
50References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 17, 2020 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Feb 17, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides binding polypeptides (e.g., antibodies or fragments thereof) that specifically bind to a target antigen (e.g., a human antigen, e.g., human PDGFRβ) with high affinity. The invention also provides, libraries of binding polypeptides, pharmaceutical compositions, as well as nucleic acids encoding binding polypeptides, recombinant expression vectors and host cells for making such binding polypeptides. Methods of using binding polypeptide of the invention to diagnose and treat disease are also encompassed by the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.